Cambridge, UK – Lab21 Limited, the Cambridge, UK-based specialist in personalised medicine and clinical diagnostics, today announced that it has acquired Microgen Bioproducts Ltd a UK company specialising in the development, manufacture and sale of diagnostic tests to identify diseases and organisms which pose a threat to health. Microgen Bioproducts’ expertise in microbiological assay development […]
The agreement completes Transgene’s biomarker strategy for the development of TG4010 in Phase IIb/III clinical trials Parc d’Innovation, Illkirch (France) – Transgene (NYSE-Euronext: TNG) announced today that the company has signed an agreement with Beckman Coulter, Inc. (NYSE: BEC), under which Beckman Coulter will develop for Transgene a companion test that measures the level of […]
TAASTRUP, Denmark – FluimediX, a point-of-care diagnostic company, announced today that PhD HC Ove Öhman has joined the Company’s Board of Directors as a non-executive Director. Mr. Öhman played an instrumental role in the founding and development of Åmic AB, a Swedish diagnostic company. He led Åmic as Chairman, Chief Executive Officer and Vice President […]
Marcy l’Etoile, France – A world leader in in vitro diagnostics, bioMérieux announces the appointment of James P. Whelan as Executive Vice President of Commercial Services. In this newly created role, he will be responsible for reinforcing bioMérieux’s global service offering. This enhanced offering will include expanded customer lab audits, laboratory accreditation support and comprehensive […]
DURHAM, N.C. – Clinicians may soon have a new tool in the diagnosis and treatment of Herpes Simplex Viruses (HSV) – one of the most common sexually transmitted infections in the world. BD Diagnostics, a segment of BD (Becton, Dickinson and Company) (NYSE: BDX), announced today that it filed for U.S. Food and Drug Administration […]
Biohit Oyj has decided to withdraw from its plans to spin off the diagnostics business until further notice. The company seeks to increase operational efficiency by merging the management of diagnostics and liquid handling sales and marketing. In the future, Jukka-Pekka Haapalahti, MSc (biochem), who was appointed Director of Liquid handling Sales and Marketing in […]
Transgenomic, Inc. (OTCBB: TBIO) announced today that it has closed the acquisition of Clinical Data, Inc.’s (NasdaqGM: CLDA) diagnostic business with a sales price of $15.5 million. In addition, the company has closed on $6.0 million of financing from Third Security, LLC, a leading life sciences investment firm, to fund the cash portion of Transgenomic’s […]
BIT Analytical Instruments, GmbH, a German company, has acquired 100% shares of C2 Diagnostics of Montpellier, France, a leader in contract development, design, manufacture and support of custom instrumentation for the diagnostic OEM industry – with a specialty in hematology. Schwalbach, Germany – BIT Analytical Instruments (https://www.BIT-instruments.com) has announced that, as of December 16, 2010, […]
Delivering Simultaneous Detection and Differentiation of Flu A, Flu B, and 2009 H1N1 Strain European Resurgence of 2009 H1N1 Highlights Need for Accurate, Rapid Flu Diagnosis SUNNYVALE, Calif. – Cepheid (Nasdaq: CPHD) today announced the release of Xpert(R) Flu as a European CE IVD Mark product under the European Directive on In Vitro Diagnostic Medical […]
Exiqon A/S (NASDAQ OMX: EXQ), a leading provider of technologies for biomarker detection, today announced the introduction of GLP compliant services for miRNA biomarker screening and diagnostic assay development for clinical trials. Exiqon is already working with a number of global pharmaceutical companies in the search for biomarkers to support their clinical programs on future […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
